Promotion of retroviral entry in the absence of envelope protein by chlorpromazine

Virology

Volumn 316, Issue 1, 2003, Pages 184-189

  Taylor, Gwen M ^a   Zullo, Alfred J ^a   Larson, Geraldine M ^a   Sanders, David Avram ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

Chlorpromazine; Envelope protein; Gene transfer; Glycoprotein; Hemifusion; Membrane fusion; Murine leukemia virus; Retrovirus; Viral entry

Indexed keywords

CHLORPROMAZINE; MEMBRANE AFFECTING AGENT; REAGENT; VIRUS ENVELOPE PROTEIN; VIRUS FUSION PROTEIN; VIRUS GLYCOPROTEIN;

ANIMAL CELL; ARTICLE; CELL FUSION; CONTROLLED STUDY; MEMBRANE FUSION; MICELLE; MOLONEY LEUKEMIA ONCOVIRUS; MOUSE; NONHUMAN; PH; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VIRUS CELL INTERACTION; VIRUS ENVELOPE; VIRUS PARTICLE;

MOLONEY MURINE LEUKEMIA VIRUS; MURINAE; MURINE LEUKEMIA VIRUS; UNIDENTIFIED RETROVIRUS;

EID: 0242352465     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virol.2003.07.004     Document Type: Article

References (30)

1. Chernomordik L.V., Frolov V.A., Léikina E., Bronk P., Zimmerberg J. The pathway of membrane fusion catalyzed by influenza hemagglutinin restriction of lipids, hemifusion, and lipidic fusion pore formation . J. Cell Biol. 140:1998;1369-1382.
2. Cohen F.S., Melikyan G.B. Methodologies in the study of cell-cell fusion. Methods. 16:1998;215-226.
3. Gallardo H.F., Tan C., Ory D., Sadelain M. Recombinant retroviruses pseudotyped with the vesicular stomatitis virus G glycoprotein mediate both stable gene transfer and pseudotransduction in human peripheral blood lymphocytes. Blood. 90:1997;952-957.
4. Henderson L.E., Sowder R., Copeland T.D., Smythers G., Oroszlan S. Quantitative separation of murine leukemia virus proteins by reversed-phase high-pressure liquid chromatography reveals newly described gag and env cleavage products. J. Virol. 52:1984;492-500.
5. Jeetendra E., Robison C.S., Albritton L.M., Whitt M.A. The membrane-proximal domain of vesicular stomatitis virus G protein functions as a membrane fusion potentiator and can induce hemifusion. J. Virol. 76:2002;12300-12311.
6. Jeffers S.A., Sanders D.A., Sanchez A. Covalent modifications of the Ebola virus glycoprotein. J. Virol. 76:2002;12463-12472.
7. Jones J.S., Risser R. Cell fusion induced by the murine leukemia virus envelope glycoprotein. J. Virol. 67:1993;67-74.
8. Liu M.L., Winther B.L., Kay M.A. Pseudotransduction of hepatocytes by using concentrated pseudotyped vesicular stomatitis virus G glycoprotein (VSV-G)-Moloney murine leukemia virus-derived retrovirus vectors comparison of VSV-G and amphotropic vectors for hepatic gene transfer . J. Virol. 70:1996;2497-2502.
9. Markosyan R.M., Cohen F.S., Melikyan G.B. The lipid-anchored ectodomain of influenza virus hemagglutinin (GPI-HA) is capable of inducing nonenlarging fusion pores. Mol. Biol. Cell. 11:2000;1143-1152.
10. Melikyan G.B., Brener S.A., Ok D.C., Cohen F.S. Inner but not outer membrane leaflets control the transition from glycosylphosphatidylinositol- anchored influenza hemagglutinin-induced hemifusion to full fusion. J. Cell Biol. 136:1997;995-1005.
11. Melikyan G.B., Lin S., Roth M.G., Cohen F.S. Amino acid sequence requirements of the transmembrane and cytoplasmic domains of influenza virus hemagglutinin for viable membrane fusion. Mol. Biol. Cell. 10:1999;1821-1836.
12. Ory D.S., Neugeboren B.A., Mulligan R.C. A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. Proc. Natl. Acad. Sci. USA. 93:1996;11400-11406.
13. Pinter A., Fleissner E. The presence of disulfide-linked gp70-p15(E) complexes in AKR murine leukemia virus. Virology. 83:1977;417-422.
14. Pinter A., Honnen W.J. Topography of murine leukemia virus envelope proteins characterization of transmembrane components . J. Virol. 46:1983;1056-1060.
15. Pinter A., Kopelman R., Li Z., Kayman S.C., Sanders D.A. Localization of the labile disulfide bond between SU and TM of the murine leukemia virus envelope protein complex to a highly conserved CWLC motif in SU that resembles the active site sequence of thiol-disulfide exchange enzymes. J. Virol. 71:1997;8073-8077.
16. Pinter A., Lieman-Hurwitz J., Fleissner E. The nature of the association between the murine leukemia virus envelope proteins. Virology. 91:1978;345-351.
17. Pizzato M., Marlow S.A., Blair E.D., Takeuchi Y. Initial binding of murine leukemia virus particles to cells does not require specific Env-receptor interaction. J. Virol. 73:1999;8599-8611.
18. Sanders D.A. Sulfhydryl involvement in fusion mechanisms. Hilderson H., Fuller S. Fusion of Biological Membranes and Related Problems. 2000;483-514 Kluwer Academic/Plenum, New York.
19. Sanders D.A. No false start for novel pseudotyped vectors. Curr. Opin. Biotechnol. 13:2002;437-442.
20. Sharkey C.M., North C.L., Kuhn R.J., Sanders D.A. Ross River virus glycoprotein-pseudotyped retroviruses and stable cell lines for their production. J. Virol. 75:2001;2653-2659.
21. Sharma S., Miyanohara A., Friedmann T. Separable mechanisms of attachment and cell uptake during retrovirus infection. J. Virol. 74:2000;10790-10795.
22. Sharma S., Murai F., Miyanohara A., Friedmann T. Noninfectious virus-like particles produced by Moloney murine leukemia virus-based retrovirus packaging cells deficient in viral envelope become infectious in the presence of lipofection reagents. Proc. Natl. Acad. Sci. USA. 94:1997;10803-10808.
23. Taylor G.M., Gao Y., Sanders D.A. Fv-4 identification of the defect in env and the mechanism of resistance to ecotropic murine leukemia virus . J. Virol. 75:2001;11244-11248.
24. Taylor G.M., Sanders D.A. The role of the membrane-spanning domain sequence in glycoprotein-mediated membrane fusion. Mol. Biol. Cell. 10:1999;2803-2815.
25. Tedesco M.M., Matile S. Spectroscopic detection of endovesiculation by large unilamellar phosphatidylcholine vesicles effects of chlorpromazine, dibucaine, and safingol . Bioorg. Med. Chem. 7:1999;1373-1379.
26. Wajnberg E., Tabak M., Nussenzveig P.A., Lopes C.M., Louro S.R. pH-dependent phase transition of chlorpromazine micellar solutions in the physiological range. Biochim. Biophys. Acta. 944:1988;185-190.
27. Williams K.L., Zullo A.J., Kaplan M.H., Brutkiewicz R.R., Deppmann C.D., Vinson C., Taparowsky E.J. BATF transgenic mice reveal a role for activator protein-1 in NKT cell development. J. Immunol. 170:2003;2417-2426.
28. Witte O.N., Tsukamoto A.A., Weissman I.L. Cellular maturation of oncornavirus glycoproteins topological arrangement of precursor and product forms in cellular membranes . Virology. 76:1977;539-553.
29. Yee J.K., Miyanohara A., LaPorte P., Bouic K., Burns J.C., Friedmann T. A general method for the generation of high-titer, pantropic retroviral vectors highly efficient infection of primary hepatocytes . Proc. Natl. Acad. Sci. USA. 91:1994;9564-9568.
30. Zhu N.L., Cannon P.M., Chen D., Anderson W.F. Mutational analysis of the fusion peptide of Moloney murine leukemia virus transmembrane protein p15E. J. Virol. 72:1998;1632-1639.